Theramex’s Eladynos recommended by NICE for post-menopausal bone disease
Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause
Read More
Tag: Bone disease
Sirana enters into collaborative research agreement with Pfizer
Companies will combine to investigate a novel treatment for a rare bone disease
Read More
- Francis Crick Institute and Medicines Discovery Catapult open applications for next KQ Labs cohort
- Novartis receives European Commission approval for Itvisma for spinal muscular atrophy
- AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project
- R1 Therapeutics forms advisory board to support advancement of AP306
- UAE launches first genomics-driven clinical trial to prevent Alzheimer’s disease
